Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).
Ann Oncol
; 29(4): 1004-1009, 2018 04 01.
Article
in En
| MEDLINE
| ID: mdl-29408977
Full text:
1
Collection:
01-internacional
Health context:
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Carboplatin
/
Paclitaxel
/
Cetuximab
/
Squamous Cell Carcinoma of Head and Neck
/
Head and Neck Neoplasms
/
Neoplasm Metastasis
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Year:
2018
Document type:
Article